• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CDRH touts lack of application backlog

Article

The Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) announced this month that for the second year in a row, its premarket review program had no backlog of 510(k)s, premarket approval applications, or PMA supplements

The Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) announced this month that for the second year in a row, its premarket review program had no backlog of 510(k)s, premarket approval applications, or PMA supplements for fiscal year 1998.

Average total review time for 510(k) applications was 114 days an improvement over 130 in 1997 and 145 in 1996. Median review time for 510(k)s that cleared in fiscal year 1998 was 83 days. CDRH cleared 46 PMAs in 1998, according to the agency. The average review time of PMAs from submission to approval was roughly 12 months, 25% less than fiscal year 1997 and 50% less than fiscal year 1996. The median total time the CDRH took to clear PMAs in 1998 was about nine months.

The program attributed improved clearance times to more companies consulting with the FDA as they plan clinical studies. They also credited pilot management initiatives the CDRH implemented this year.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.